Just a few thoughts for all to consider on a humid
Post# of 87301
(Total Views: 416)
Posted On: 08/20/2019 2:32:22 PM
Just a few thoughts for all to consider on a humid summer day. Today, few industries are booming as big as the extraction industry is right now. And, whether it is cannabis or hemp, high-quality end products are in high demand and in short supply. Everyday consumers are becoming savvier like never before, closely scrutinizing the products they buy from this industry. Often, the labels are confusing, and the dose is difficult to ascertain even when clearly stated. For example, if the label tells one to take half an eye dropper of CBD oil, but the pipet on the dropper is not calibrated, then how much are you taking? Does half an eyedropper mean from the tip to half way, or does it mean something else.
High-quality end products require high-quality methods of production and processing. Large yields of high-quality products require innovation and technology in order to scale for increased consumer demand --- all while keeping production costs at a minimum. Honesty, integrity, and trustworthiness are the coins of the realm in this environment, and the best companies strive to meet all these criteria. But without FDA approval, what can a company do? In Doctor Dalton’s case, he sought CARF approval which is the next best thing to FDA approval. Other methods include Kosher Certification, and still others attempt to develop industry standards. In the end, the very best cannabis companies are likely to embrace all of these standards.
In the rush to succeed in this industry, it's easy to overlook the increasing impact that GMP (Good Manufacturing Process) compliance will have on consumer products. Not all extraction methods bode well for GMP compliance, as many big companies are now finding out. Perhaps this is what Doctor Dalton truly means when is says the last will finish first. I suspect we are soon to find out.
Kgem
High-quality end products require high-quality methods of production and processing. Large yields of high-quality products require innovation and technology in order to scale for increased consumer demand --- all while keeping production costs at a minimum. Honesty, integrity, and trustworthiness are the coins of the realm in this environment, and the best companies strive to meet all these criteria. But without FDA approval, what can a company do? In Doctor Dalton’s case, he sought CARF approval which is the next best thing to FDA approval. Other methods include Kosher Certification, and still others attempt to develop industry standards. In the end, the very best cannabis companies are likely to embrace all of these standards.
In the rush to succeed in this industry, it's easy to overlook the increasing impact that GMP (Good Manufacturing Process) compliance will have on consumer products. Not all extraction methods bode well for GMP compliance, as many big companies are now finding out. Perhaps this is what Doctor Dalton truly means when is says the last will finish first. I suspect we are soon to find out.
Kgem
(3)
(0)